These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3452239

  • 1. Clinical and pathophysiological aspects of chronic active hepatitis.
    Iwamura K.
    Tokai J Exp Clin Med; 1986; 11 Suppl():147-57. PubMed ID: 3452239
    [Abstract] [Full Text] [Related]

  • 2. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A, Sekiya C, Yazaki Y, Tominaga Y, Oohara K, Ono M, Sato H, Hasebe C, Namiki M.
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [Abstract] [Full Text] [Related]

  • 3. [Morphologic findings in liver tissue in chronic active hepatitis B after seroconversion from HBeAg to anti-HBe].
    Chlumská A, Stránský J, Taimr P, Baumruk L, Nevaril M.
    Vnitr Lek; 1995 Jul; 41(7):445-8. PubMed ID: 7571477
    [Abstract] [Full Text] [Related]

  • 4. HBeAg/anti-HBe antigenic system in liver diseases in Greece.
    Theodoropoulos G, Nakopoulou L, Fertakis A, Papaevangelou G, Hadzis G, Kasfiki A.
    Hepatogastroenterology; 1983 Dec; 30(6):243-5. PubMed ID: 6327477
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS, Sung JL, Lai MY.
    Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
    [Abstract] [Full Text] [Related]

  • 6. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
    Tsuchie H, Kurimura O, Tamura I, Shimase K, Kaneto E, Kurimura T, Tsuda F, Mayumi M.
    Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
    [Abstract] [Full Text] [Related]

  • 7. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
    Sodeyama T, Kiyosawa K, Akahane Y, Tanaka E, Wada S, Oike Y, Nakamura M, Yoda H, Imai Y, Gibo Y.
    Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
    [Abstract] [Full Text] [Related]

  • 8. [Prognostic significance of the HBeAg-anti-HBe system in acute hepatitis B].
    Ketiladze ES, Vorozhbieva TE, Matveev VA, Bugaeva NP.
    Ter Arkh; 1986 Apr; 58(10):23-6. PubMed ID: 3798343
    [No Abstract] [Full Text] [Related]

  • 9. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B.
    Niermeijer P, Gips CH, Huizenga JR, van der Waart M, Schuurs A.
    Hepatogastroenterology; 1980 Oct; 27(5):350-5. PubMed ID: 7203369
    [Abstract] [Full Text] [Related]

  • 10. [Clinico-prognostic significance of partial seroconversion in chronic viral hepatitis B follow-up. Wartenbert Study (1974-1994), II].
    Ohlen I, Liegl JM, Selmair H.
    Leber Magen Darm; 1995 Dec; 25(6):259-62. PubMed ID: 8577215
    [Abstract] [Full Text] [Related]

  • 11. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B, Nazarewicz-de Mezer T, Krawczyński K.
    Przegl Epidemiol; 1984 Dec; 38(3):249-56. PubMed ID: 6528039
    [No Abstract] [Full Text] [Related]

  • 12. The HBe antigen-antibody system and its relationship to epidemiological, histological and biochemical findings in patients with HBV+ HDV chronic liver diseases.
    Jelić D, Jelić O.
    Acta Med Croatica; 1994 Dec; 48(2):77-83. PubMed ID: 7519502
    [Abstract] [Full Text] [Related]

  • 13. [e/Anti-e system in liver disease].
    Resta ML, Freni MA, Berlinghieri G, Ajello A, Crinò M, Ferraù O.
    Boll Soc Ital Biol Sper; 1980 Oct 30; 56(20):2123-8. PubMed ID: 7459125
    [Abstract] [Full Text] [Related]

  • 14. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
    Caredda F, D'Arminio Monforte A, Rossi E, Cultraro D, Marescotti C, Moroni M.
    Boll Ist Sieroter Milan; 1981 Oct 30; 60(6):468-79. PubMed ID: 7344717
    [No Abstract] [Full Text] [Related]

  • 15. Effects of alcohol on the liver in HBsAg carriers.
    Itoh S, Shimoji K.
    Am J Gastroenterol; 1986 Sep 30; 81(9):779-82. PubMed ID: 3752040
    [Abstract] [Full Text] [Related]

  • 16. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
    Reichlin B, Stalder GA, Gudat F, Bianchi L, Froesner GG.
    Schweiz Med Wochenschr; 1982 Apr 12; 112(15):523-4. PubMed ID: 7079688
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of HBeAg and HBsAg seroconversion in patients with chronic hepatitis B.
    Stránský J, Chlumská A, Zichová M, Helm R, Mankovecký L, König J.
    Sb Lek; 1993 Apr 12; 94(4):317-25. PubMed ID: 7992018
    [Abstract] [Full Text] [Related]

  • 18. [Seroconversion of HBeAg into anti-HBe in chronic hepatitis type B].
    Stránský J, Vodák M, Zichová M, Votruba T, Choluj B.
    Cas Lek Cesk; 1986 Oct 31; 125(44):1353-6. PubMed ID: 3508397
    [No Abstract] [Full Text] [Related]

  • 19. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
    Hasan KN, Rumi MA, Hasanat MA, Azam MG, Ahmed S, Salam MA, Islam LN, Hassan MS.
    Southeast Asian J Trop Med Public Health; 2002 Mar 31; 33(1):110-7. PubMed ID: 12118438
    [Abstract] [Full Text] [Related]

  • 20. [Spontaneous seroconversion of HBeAg into anti-HBe in patients with chronic hepatitis B].
    Hadzić N, Vucelić B, Dubravcić D, Juricić M, Stavljenić A.
    Lijec Vjesn; 1988 Mar 31; 110(6-7):181-4. PubMed ID: 3185086
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.